Back to Search
TINA ROMAN, MD
MD
Pediatrics Physician
NPI: 1851304869Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
036129(CT)
Research & Publications (20)
MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder.
PMID 19309535·Int J Neuropsychopharmacol·2009
4-observational
A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder.
PMID 18802919·Am J Med Genet B Neuropsychiatr Genet·2008
8-other
22q11.2 deletion syndrome in patients admitted to a cardiac pediatric intensive care unit in Brazil.
PMID 18512234·Am J Med Genet A·2008
8-other
Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type.
PMID 18200436·J Neural Transm (Vienna)·2008
3-trial
A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children.
PMID 17044101·Am J Med Genet B Neuropsychiatr Genet·2007
8-other
Tobacco smoking and the ADRA2A C-1291G polymorphism.
PMID 17612790·J Neural Transm (Vienna)·2007
8-other
Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
PMID 17283289·Arch Gen Psychiatry·2007
3-trial
No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder.
PMID 17171656·Am J Med Genet B Neuropsychiatr Genet·2007
3-trial
Serotonin genes and attention deficit/hyperactivity disorder in a Brazilian sample: preferential transmission of the HTR2A 452His allele to affected boys.
PMID 16958038·Am J Med Genet B Neuropsychiatr Genet·2007
7-preclinical
Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder.
PMID 16172611·Mol Psychiatry·2006
8-other
No association between dopaminergic polymorphisms and intelligence variability in attention-deficit/hyperactivity disorder.
PMID 17130883·Mol Psychiatry·2006
4-observational
Association between alpha-2a-adrenergic receptor gene and ADHD inattentive type.
PMID 16806103·Biol Psychiatry·2006
4-observational
Association between DRD4 gene and performance of children with ADHD in a test of sustained attention.
PMID 16781678·Biol Psychiatry·2006
4-observational
Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder.
PMID 15389753·Am J Med Genet B Neuropsychiatr Genet·2005
4-observational
Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.
PMID 16013954·Pharmacogenomics·2005
1-meta
Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
PMID 15059031·Am J Pharmacogenomics·2004
6-review
Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes.
PMID 14732906·Am J Hum Genet·2004
8-other
Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics.
PMID 12629578·Pharmacogenomics J·2003
6-review
Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder?
PMID 12815749·Am J Med Genet B Neuropsychiatr Genet·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 540 SAYBROOK RD, SUITE 100
MIDDLETOWN, CT 06457 - Phone
- (860) 347-6683
Quick Facts
- NPI
- 1851304869
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile